Building a model to determine the cost-effectiveness of breast cancer screening in France

European Journal of Cancer Care

Volumn 12, Issue 2, 2003, Pages 143-153

  Arveux, P ^a   Wait, Suzanne ^b   Schaffer, P ^b  

^a HÔPITAL SAINT JACQUES   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Breast; Cancer; Cost effectiveness; Model; Screening

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; COHORT ANALYSIS; COST BENEFIT ANALYSIS; EPIDEMIOLOGICAL DATA; FEASIBILITY STUDY; FEMALE; FRANCE; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PILOT STUDY; PROBABILITY; RADIOLOGY; REGISTER; SIMULATION; VALIDATION PROCESS; AGED; BREAST TUMOR; COST; ECONOMICS; MASS SCREENING; MIDDLE AGED; STATISTICAL MODEL; VALIDATION STUDY;

AGED; BREAST NEOPLASMS; COHORT STUDIES; COSTS AND COST ANALYSIS; FEMALE; FRANCE; HUMANS; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMIC;

EID: 0141560522     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2354.2003.00373.x     Document Type: Article

References (49)

1. Arveux P., Lejeune C. & Pitard A. (1998) What are the costs of an effcient screening strategy for colonic cancer? Gastroenterology and Clinical Biology 22, S49-S55.
2. Auray J.P., Bail J.N., Béraud C., Beresniak A., Balchier C. & Corchaud S. (1998) Recommandations de bonnes pratiques des méthodes d'évaluation économique des stratégies thé rapeutiques. Journal of Econ Médicale 16, 329-351.
3. Australian Health Minister's Advisory Council (1990). Breast cancer screening evaluation committee. Australian institute of health prevention program evaluation series no. 1. Australian Government Publishing Service, Canberra.
4. Beemsterboer P.M.M., de Koning H.J., Warmerdam P.G. et al. (1994) Prediction of the effects and costs of breast cancer screening in Germany. International Journal of Cancer 58, 623-628.
5. Bonnier P., Body G., Bessenay F. et al. (1999) Prognostic factors in ductal carcinoma in situ of the breast: results of a retrospective study of 575 cases. The Association for Research in Oncologic Gynecology. European Journal of Obstetric Gynecological Reproduction Biology 84, 27-35.
6. Brown M.L. (1992) Economic considerations in breast cancer screening of older women. Journal of Gerontology 47, 51-58.
7. Carter C.L., Allen C. & Henson D.E. (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63, 181-187.
8. Clarke P.R. & Fraser N.M. (1991) Economic analysis of screening for breast cancer. Report for the Scottish Home and Health Department 1991.
9. Crisp W.J., Higgs M.J., Cowan W.K. et al. (1993) Screening for breast cancer detects tumours at an earlier biological stage. British Journal of Surgery 80, 863-865.
10. Day N.E., Williams D.R.R. & Khaw K.T. (1989) Breast cancer screening programmes: the development of a monitoring and evaluation system. British Journal of Cancer 59, 954-958.
11. Dickman P., Hakulinen T., Luostarinen T. et al. (1999) Survival of cancer patients in Finland 1955-94. Acta Oncologica 38, 1-103.
12. Duffy S.W., Tabar L., Faberberg G. et al. (1991) Breast screening, prognostic factors and survival results from the Swedish two-county study. British Journal of Cancer 6, 1133-1138.
13. Eddy D.M. (1989) Screening for breast cancer. Annals of Internal Medicine 111, 389-399.
14. Ernster V.L., Barclay J., Kerlikowske K., Grady D. & Henderson C. (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. Journal of the American Medical Association 275, 913-918.
15. Forrest P. (1987) Breast Cancer Screening Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. Department of Health Social Security, HMSO, London.
16. Galea M.H., Todd J.H., Elston C.W., Ellis I.O. & Blamey R.W. (1991) Confirmation of a prognostic index for primary breast cancer. European Journal of Surgery - Oncology 17, 414.
17. Goetszche P.C. & Olsen O. (2000) Is screening for breast cancer with mammography justifiable? Lancet 355, 129-134.
18. Hall J., Gerard K., Salkeld G. & Richardson J. (1992) A cost-utility analysis of mammographic screening in Australia. Society of Science Medicine 34, 993-1004.
19. Haybitte J.L., Blamey R.W., Elston C.W. et al. (1982) A prognostic index in primary breast cancer. British Journal of Cancer 45, 361-366.
20. Hayes D.F. & Kaplan W. (1990) Evaluation of Patients Following Primary Therapy. pp. 505-525. Lippencott, Philadelphia.
21. Hristova L. & Hakama M. (1996) Effect of screening for cancer in the nordic countries on deaths, costs and quality of life up to the year 2017. Acta Oncology (Suppl 9). Scandinavian University Press, Stockholm.
22. van Ineveld B.M., van Oortmarssen G.J., de Koning H.J., Boer R. & van der Maas P.J. (1993) How cost-effective is breast cancer screening in different EC countries? European Journal of Cancer 29A, 1663-1668.
23. Institut National Statistique et des Etudes Sociales (INSEE) (2000) Recensement de la Population, Projections Omphale. INSEE, Paris.
24. de Koning H.J., van Ineveld B.M., van Oortmarssen G.J. et al. (1991) Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors. International Journal of Cancer 49, 531-537.
25. Leivo T., Sintonen H. & Tuominen R. & Hakama M. & Pukkal E. & Heinonen O.-P. (1999) The cost-effectiveness of nationwide breast carcinoma screening in Finland 1987-92. Cancer 86, 638-646.
26. Lejeune C., Arveux P., Fagnani F., Bonithon-Kopp C. & Faivre J. (2003) A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer. European Journal of Cancer Prevention 12, 77-84.
27. van der Maas P.J., de Koning H.J., van Ineveld B.M. et al. (1989) The cost-effectiveness of breast cancer screening. International Journal of Cancer 43, 1055-1060.
28. McCann J. & Stockton D. & Day N. (1998) Breast cancer in East Anglia. the impact of the breast cancer screening programme on stage at diagnosis. Journal of Medical Screening 5, 42-48.
29. Moss S. & Blanks R. (1998) Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Journal of Epidemiology and Community Health 52, 111-115.
30. Moss S.M. & Ellman R. & Coleman D. & Chamberlain J. for the United Kingdom Trial of Early Detection of Breast Cancer Group. (1994) Survival of patients with breast cancer diagnosed in the United Kingdom trial of early detection of breast cancer. Journal of Medical Screening 1, 193-198.
31. Norum J. (1999) Breast cancer screening by mammography in Norway. Is it cost-effective? Annals of Oncology 10, 197-203.
32. Obuko I., Glick H., Frumkin H. & Eisenberg J.M. (1991) Cost-effectiveness analysis of mass screening for breast cancer in Japan. Cancer 7, 2021-2029.
33. van Oortmarssen G.J. & Boer R. & Habbema J.D. (1995) Modelling issues in cancer screening. Statistical Methods in Medical Research 4, 33-54.
34. Page D.L. & Dupont W.D. & Rogers L.W. (1984) Intra-ductal carcinoma of the breast: Follow-up after biopsy only. Cancer 49, 751-758.
35. Plans P. & Casademont L. & Salleras L. (1996) Cost-effectiveness of breast cancer screening in Spain. International Journal of Technological Assessment of Health Care 12, 146-150.
36. Royston G. (1999) Commentary: trials versus models in appraising screening programmes. British Medical Journal 318, 360-361.
37. Schaffer P. & Renaud R. & Gairard B. & Guldenfels C. (1996) Le rôle des registres dans l'évaluation des campagnes de dépistage du cancer du sein. Rev Epidém et Santé Publications 44, S15-S21.
38. Schaffer P., Gairard B., Guldenfels C. & Haehnel P. et al. (2000) Un système decentralisé de dépistage du cancer du sein: l'exemple du Bas-Rhin en France. [A decentralized breast cancer screening program in the French department of Bas-Rhin.] Journal of Radiology 81, 845-857.
39. Schwartz M. (1980) Estimates of lead time and length biasing in a breast cancer screening program. Cancer 46, 844-851.
40. Séradour B. & Allemand H. & Schaffer P. (1997) Programme français de dépistage du cancer du sein. Résultats de Cinq Départements 1989-94. Bulletin Cancer 84, 822-828.
41. Sonnenberg F.A. & Beck J.R. (1993) Markov models in medical decision making: a practical guide. Medical Decision Making 13, 322-338.
42. Tabar L., Fagerberg G., Duffy S.W. & Day N.E. (1989) The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. Journal of Epidemiology and Community Health, 43, 107-114.
43. U.S. Congress Office of Technology Assessment. (1987) Breast Cancer Screening for Medicare Beneficiaries: Effectiveness, Costs to Medicare and Medical Resources Required. US Government Printing Office, Washington, DC.
44. Wait S. & Allemand H. (1996) The French breast cancer screening programme: epidemiological and economic results of the first round of screening. European Journal of Public Health 6, 43-48.
45. Wait S., Schaffer P., Seradour B., Chollot M., Demay M. & Dejouhanet S. (1997) Le dépistage spontané du cancer du sein. [Opportunistic screening of breast cancer in France.] Bulletin Cancer 84, 619-624.
46. Wait S., Schaffer P., Seradour B, et al. (2000a) Le coût du dépistage du cancer du sein en France. [The cost of breast cancer screening in France]. Journal of Radiologie 81, 799-806.
47. Wait S., Schaffer P., Blanchard O. & le Bas-Rhin. J. (2000b) La prise en charge hospitalière du cancer du sein dans. Econ Médicale 18, 85-100.
48. de Wolf C.J.M. & Perry N.M. (June 1996) European Guidelines for Quality Assurance in Mammography Screening, 2nd edn. European Commission.
49. Wright C. & Mueller C. (1995) Screening mammography and public health policy: the need for perspective. Lancet 346, 29-32.